Gary Adams Jr, RPH | |
900 E Admiral Doyle Dr, New Iberia, LA 70560-6709 | |
(337) 367-2291 | |
(337) 365-0162 |
Full Name | Gary Adams Jr |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 900 E Admiral Doyle Dr, New Iberia, Louisiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255732814 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | PST.017491 (Louisiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Gary Adams Jr, RPH 900 E Admiral Doyle Dr, New Iberia, LA 70560-6709 Ph: (337) 367-2291 | Gary Adams Jr, RPH 900 E Admiral Doyle Dr, New Iberia, LA 70560-6709 Ph: (337) 367-2291 |
News Archive
Repligen Corporation announced today that the United States Patent and Trademark Office has granted a Notice of Allowance of a patent covering the use of uridine in the treatment of patients with bipolar disorder. The patent, which upon issue will remain in force until 2025 prior to any patent term extensions, covers the use of an effective dose of a uridine composition to improve one or more of the symptoms of bipolar disorder including depression, mania, mixed episodes, hypomania and anxiety.
Former U.S. Senator Alan Simpson, co-chairman of President Barack Obama's fiscal commission, said escalating Medicare costs stand to squeeze out the rest of domestic government spending. "Medicare is on automatic pilot. It will use up every resource in the government," the Republican former senator from Wyoming said in an interview today on Bloomberg Television.
NewYork-Presbyterian Hospital/Columbia University Medical Center has established a new center devoted to research and treatment of pre-leukemia blood disorders. Known as the Myelodysplastic Syndromes Center, it is one of the largest programs of its kind in the nation.
Humana Inc. and Novo Nordisk Inc. today announced a one-year research partnership to explore diabetes treatment and care. Together, researchers will identify opportunities to change how patients might be treated to improve quality and outcomes for the millions of people who battle diabetes.
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and fibrotic organ failure, announced today that its lead clinical candidate STX-100 has been granted orphan drug status by the U.S. Food and Drug Administration for the treatment of idiopathic pulmonary fibrosis, a debilitating and almost uniformly fatal disease in which patients experience progressive difficulty breathing due to fibrosis (scarring) of the lung.
› Verified 4 days ago
Tami Leigh Willingham, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 185 N Lewis St, New Iberia, LA 70563 Phone: 337-365-2323 | |
Nguyet Le, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1205 E Admiral Doyle Dr, New Iberia, LA 70560 Phone: 337-364-3841 Fax: 337-364-3843 | |
Holly Lamm, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 185 N Lewis St, New Iberia, LA 70563 Phone: 337-365-2323 | |
Sidney Champagne, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 106 Candleglow Dr, New Iberia, LA 70563 Phone: 337-560-1096 | |
Mr. Philip C Aucoin, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1104 East Main St, New Iberia, LA 70560 Phone: 337-365-8048 Fax: 337-365-5350 | |
Lynez Cecilia Preyan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1108 E Main St, New Iberia, LA 70560 Phone: 337-365-4514 | |
Mr. Tommy Anthony Leleux, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1102 Parkview Dr, New Iberia, LA 70563 Phone: 337-560-1807 |